Literature DB >> 18500460

Coexistence of familial Mediterranean fever and psoriasis in a patient with seronegative spondyloarthropathy.

Hatice Bodur1, Umit Seçkin, Filiz Eser, Gülüşan Ergül, Selda Seçkin.   

Abstract

Familial Mediterranean fever (FMF) is a self-limited disease characterized by fever and polyserositis attacks. Arthritis caused by synovitis is either in acute monoarthritis or chronic mono-oligoarthritis form, usually affecting the lower extremities. Another potential but rare form of involvement is spondyloarthropathy (SSpA). Psoriatic arthritis (PsA) is inflammatory arthropathy of peripheral joints, spine and enthesis areas. Some PsA cases are classified as psoriatic spondyloarthropathy. A 43-year-old male patient with concomitant FMF and psoriasis presenting with bilateral sacroiliitis, chronic hip and knee arthritis has been presented along with follow-up findings and treatment options used.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18500460     DOI: 10.1007/s00296-008-0616-6

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  18 in total

1.  Protracted familial Mediterranean fever arthritis.

Authors:  H Bodur; H Uçan; S Seçkin; U Seçkin; O H Gündüz
Journal:  Rheumatol Int       Date:  1999       Impact factor: 2.631

2.  Sacroiliitis in familial Mediterranean fever and seronegative spondyloarthropathy: importance of differential diagnosis.

Authors:  Birol Balaban; Evren Yasar; Ahmet Ozgul; Kemal Dincer; Tunc Alp Kalyon
Journal:  Rheumatol Int       Date:  2005-02-12       Impact factor: 2.631

3.  Familial Mediterranean fever successfully treated with etanercept.

Authors:  Adam Mor; Michael H Pillinger; Mitsumasa Kishimoto; Aryeh M Abeles; Avi Livneh
Journal:  J Clin Rheumatol       Date:  2007-02       Impact factor: 3.517

4.  Treatment options in colchicine resistant familial Mediterranean fever patients: thalidomide and etanercept as adjunctive agents.

Authors:  E Seyahi; H Ozdogan; S Celik; S Ugurlu; H Yazici
Journal:  Clin Exp Rheumatol       Date:  2006 Sep-Oct       Impact factor: 4.473

5.  Familial Mediterranean fever responds well to infliximab: single case experience.

Authors:  Salih Ozgocmen; Levent Ozçakar; Ozge Ardicoglu; Ercan Kocakoc; Arzu Kaya; Adem Kiris
Journal:  Clin Rheumatol       Date:  2005-09-20       Impact factor: 2.980

6.  Juvenile psoriatic arthritis carrying familial Mediterranean fever gene mutations in a 14-year-old Turkish girl.

Authors:  Betul Sozeri Yeniay; Neslihan Edeer Karaca; Seciye Eda Yuksel; Levent Midyat; Necil Kutukculer
Journal:  J Dermatol       Date:  2007-05       Impact factor: 4.005

7.  Etanercept in the treatment of arthritis in a patient with familial Mediterranean fever.

Authors:  O Sakallioglu; A Duzova; S Ozen
Journal:  Clin Exp Rheumatol       Date:  2006 Jul-Aug       Impact factor: 4.473

Review 8.  Psoriatic arthritis assessment tools in clinical trials.

Authors:  P J Mease; C E Antoni; D D Gladman; W J Taylor
Journal:  Ann Rheum Dis       Date:  2005-03       Impact factor: 19.103

Review 9.  Psoriatic arthritis update.

Authors:  Philip Mease
Journal:  Bull NYU Hosp Jt Dis       Date:  2006

10.  Coexistence of familial Mediterranean fever with sacroiliitis and Behçet's disease: a rare occurrence.

Authors:  M Birlik; M Tunca; N Hizli; M Soytürk; Y Yeniçerioğlu; M A Ozcan; O El
Journal:  Clin Rheumatol       Date:  1998       Impact factor: 2.980

View more
  5 in total

Review 1.  Infliximab therapy for familial Mediterranean fever-related amyloidosis: case series with long term follow-up.

Authors:  Z Birsin Özçakar; Selçuk Yüksel; Mesiha Ekim; Fatoş Yalçınkaya
Journal:  Clin Rheumatol       Date:  2012-06-07       Impact factor: 2.980

Review 2.  Biological treatments: new weapons in the management of monogenic autoinflammatory disorders.

Authors:  Antonio Vitale; Donato Rigante; Orso Maria Lucherini; Francesco Caso; Isabella Muscari; Flora Magnotti; Maria Giuseppina Brizi; Susanna Guerrini; Maria Patti; Leonardo Punzi; Mauro Galeazzi; Luca Cantarini
Journal:  Mediators Inflamm       Date:  2013-07-21       Impact factor: 4.711

3.  Increased psoriasis frequency in patients with familial Mediterranean fever.

Authors:  Abdulsamet Erden; Ezgi Deniz Batu; Emrah Seyhoğlu; Alper Sari; Hafize Emine Sönmez; Berkan Armagan; Selcan Demir; Emre Bilgin; Levent Kilic; Omer Karadag; Ali Akdogan; Yelda Bilginer; Ihsan Ertenli; Sedat Kiraz; Sule Apras Bilgen; Umut Kalyoncu
Journal:  Ups J Med Sci       Date:  2018-01-24       Impact factor: 2.384

4.  FMF Is Associated With a Wide Spectrum of MHC Class I- and Allied SpA Disorders but Not With Classical MHC Class II-Associated Autoimmune Disease: Insights From a Large Cohort Study.

Authors:  Abdulla Watad; Nicola Luigi Bragazzi; Mohammad Adawi; Yehuda Shoenfeld; Doron Comaneshter; Arnon D Cohen; Dennis McGonagle; Howard Amital
Journal:  Front Immunol       Date:  2019-11-26       Impact factor: 7.561

5.  Coexisting Diseases in Patients with Familial Mediterranean Fever.

Authors:  Farhad Salehzadeh; Afsaneh Enteshari Moghaddam
Journal:  Open Access Rheumatol       Date:  2020-05-28
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.